FSD Pharma Inc. (HUGE.CN)

2.1500 -0.0700 (-3.15%) At close: 3:59PM EST

FSD Pharma Inc.

First Canadian Place
Suite 3400 100 King Street West
Toronto, ON M5X 1A4
Canada

http://fsdpharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 17

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Raza Bokhari M.B.A., M.D., MBA	Exec. Chairman & CEO	1	N/A	1968
Mr. Anthony John Durkacz	Founder & Director	N/A	N/A	1976
Mr. Donal Carroll CPA	Chief Financial Officer	58.67k	N/A	1977
Dr. Sara May Ph.D.	Sr. VP	N/A	N/A	N/A
Dr. Sandra R. Lottes	VP & Head of Clinical Research of FSD BioSciences, Inc	N/A	N/A	N/A
Ms. Maryann Adesso	Chief of Staff	N/A	N/A	N/A
Dr. Edward J. Brennan Jr., F.A.C.S., M.D., FACS	Pres of FSD BioSciences, Inc	N/A	N/A	N/A

Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Toronto, Canada.

Corporate Governance

FSD Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.